Hemp companies are preparing for the hemp THC ban in different ways – but for now, it’s business as usual.
Chris Roberts
Chris Roberts's Latest Posts
Epstein files victory creates opportunity for hemp THC supporter
Political victory with the Epstein files raises the profile and the political capital of key hemp THC supporter U.S. Rep. Thomas Massie of Kentucky.
Marijuana operators not waiting for federal hemp ban to halt THCA sales
A lawsuit filed last week by Missouri marijuana businesses after President Donald Trump signed the hemp ban into law seeks immediate action.
Can ‘functional THC’ move cannabis past the potency race?
Cannabis operators embracing the functional THC movement may break the cycle of THC addiction.
US cities cutting back on permitted cannabis businesses
Rapid City, South Dakota, might cut the number of medical cannabis dispensaries permitted in city limits from 10 to 5.
Will the cannabis tax revolt succeed?
Cannabis operators around the country are staging a tax revolt. Past history suggests it may not work out the way they hope.
What happens if states ignore the federal hemp THC ban?
Even skeptics of hemp-derived THC think that hemp beverages are here to stay.
364 days until federal hemp THC prohibition as President Trump signs ban
Congress passed a spending bill late Wednesday that also bans hemp-derived THC.
Distressed marijuana MSO Ayr Wellness sells off assets in foreclosure sale
Distressed MSO Ayr Wellness sold off assets in seven states to its former creditors on Tuesday.
Hemp THC ‘prohibition’ looms as U.S. Senate closes 2018 Farm Bill ‘loophole’
In a rare win at the federal level for state-regulated legal cannabis, the Senate passed a de-facto ban on hemp-derived THC products.
President Trump backs hemp THC ban included in government reopening deal
A budget deal to reopen the government backed by President Trump would ban nearly all of the products now sold containing hemp-derived THC.
How a woman-led biotech firm is advancing cannabis medicine
Millions of women around the world live with an incurable and poorly treated condition, and many are turning to cannabis products for relief - despite inconsistent results and the risk of untested products. For Melissa Sturgess, the CEO of London-based biotech firm...
